Jefferies Financial Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1M | Buy |
2,199,652
+1,384,652
| +170% | +$19M | 0.25% | 50 |
|
|
2025
Q1 | $9.01M | Sell |
815,000
-150,929
| -16% | -$1.67M | 0.08% | 115 |
|
|
2024
Q4 | $10.3M | Buy |
965,929
+929
| +0.1% | +$9.89K | 0.06% | 149 |
|
|
2024
Q3 | $12.3M | Hold |
965,000
| – | – | 0.09% | 85 |
|
|
2024
Q2 | $16.2M | Buy |
965,000
+125,000
| +15% | +$2.1M | 0.17% | 56 |
|
|
2024
Q1 | $12.6M | Buy |
+840,000
| New | +$12.6M | 0.12% | 76 |
|